1 Huge Warning Sign in Tonix Pharmaceuticals' Earnings
Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) have been highly volatile since the company entered the race to develop a new COVID-19 vaccine. Investors saw this biotech stock double in February, only to give back much of those gains.
When the company reported results for the first three months of 2021, investors got an earful about potential new drugs and diagnostic tools in development. With lots to look forward to, it's easy to miss signs that could signal trouble ahead.
Image source: Getty Images.
Source Fool.com
